Identification of Therapeutic Targets for Osteoporosis through Multiomics Integration and the Potential Dual Role of

Jun Du1, Minjun Chang2, Kunlong Jiang2

  • 1Department of Orthopedic Magnetic Resonance Chamber, The First Affiliated Hospital of Soochow University, No. 899 Pinghai Road, Suzhou 215000, China.

Insights

This study reveals the androgen receptor's (AR) dual role in osteoporosis, identifying AR antagonists as promising treatments. Targeting AR signaling with drugs like cyproterone acetate may effectively combat bone resorption.

Area of Science:

  • Biomedical research
  • Genomics
  • Pharmacology

Background:

  • Osteoporosis involves complex cellular and molecular mechanisms.
  • Androgen receptor (AR) signaling is implicated in bone pathophysiology, but its precise role is not fully understood.

Purpose of the Study:

  • To investigate potential therapeutic targets for osteoporosis using a multiomics approach.
  • To explore the dual role of androgen receptor (AR) signaling in osteoporosis.
  • To identify effective drug candidates for treating bone resorption.

Main Methods:

  • Analysis of single-cell RNA sequencing data (GSE147287) to identify cell types and developmental trajectories.
  • Differential miRNA analysis and integrated database analysis to identify hub genes.
  • Construction of drug-gene-miRNA interaction networks, including DeepPurpose analysis, drug MoA, and molecular docking.
  • In vitro experiments to assess drug efficacy on osteoclastogenesis.

Main Results:

  • Nine major cell types and their trajectories were identified in osteoporosis samples.
  • Nineteen dysregulated miRNAs and six hub genes, including AR, were identified.
  • AR is highly expressed in tissue stem cells and involved in myeloid cell activation and osteoclast differentiation.
  • Cyproterone acetate (AR antagonist) showed stronger binding affinity to AR and superior inhibition of osteoclastogenesis compared to norethisterone (AR agonist).

Conclusions:

  • Androgen receptor (AR) signaling plays a dual role in osteoporosis pathophysiology.
  • Targeting AR with antagonists, such as cyproterone acetate, presents a promising therapeutic strategy for osteoporosis and bone resorption.

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.0K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.5K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.0K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.7K
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
9.4K